ZukoBid.
Try it free
Federal contractor profile

Ppd Development LP

Wilmington, NC · Not a small business
UEI ZANENSW6C665 · CAGE 3FAW2
Contracts won
10
since Dec 2023 · last Sep 2026
Total value
$567M
including options
Buying offices
5
government offices it sold to
Usual competition
1 offer
57% of its wins had one offer

Wins by fiscal year

FY2024
7 · $492M
FY2026
3 · $75M

Who it sells to

National Institutes Of Health Niaid
National Institutes Of Health · 3 wins · $283M
National Institutes Of Health Olao
National Institutes Of Health · 2 wins · $53M
National Institutes Of Health Nida
National Institutes Of Health · 2 wins · $6.6M
Fda Office Of Acq Grant Svcs
Food And Drug Administration · 2 wins · $2.0M
Barda - Aspr / Daappo / Barda Dcma
Administration For Strategic Preparedness And Response · 1 win · $222M

What it wins

Health R&D Services; Health Care Services; Applied Research
PSC AN12 · 6 wins · $468M
Health R&D Services; Health Care - Other; Applied Research
PSC AN42 · 2 wins · $97M
General Science And Technology R&D Services; General Science And Technology; Basic Research
PSC AJ11 · 1 win · $1.3M
Special Studies/Analysis- Scientific Data
PSC B529 · 1 win · $724K

Ending in the next 12 months

Contracts that end soon are usually re-bid. These could be openings for a competitor.
Task Order Award- Phase I Clinical Trials For The Development Of Neurotherapeutics- Dti-117 In Healthy Volunteers/Sad And Mad Ct
National Institutes Of Health Olao · ends Apr 2027 · $5.1M
Baa-Fy24c3cp5-Understanding Heterogeneity In Preferences For Clinical Trial Participation In Diverse Patient Populations.
Fda Office Of Acq Grant Svcs · ends Jul 2027 · $1.3M
Fdabaa-24-00123, Ref # Fy24c1ep6, Cardiovascular-Kidney-Metabolic (Ckm) Syndrome Patient-Reported Outcome (Pro) Burden Measure
Fda Office Of Acq Grant Svcs · ends Nov 2026 · $724K

Recent awards

DateWhatOfficeValueOffers
Sep 2026Vaccine Manufacturing Services For Infectious DiseasesNational Institutes Of Health Olao$48M30
Jun 2026Task Order Award- Phase I Clinical Trials For The Development Of Neurotherapeutics- Dti-117 In Healthy Volunteers/Sad And Mad CtNational Institutes Of Health Olao$5.1M2
Dec 2025Daids Monitoring For 1 Phase Iii Study: A5300b/I2003b (Phoenix)National Institutes Of Health Niaid$22M—
Sep 2024Baa-Fy24c3cp5-Understanding Heterogeneity In Preferences For Clinical Trial Participation In Diverse Patient Populations.Fda Office Of Acq Grant Svcs$1.3M1
Sep 2024Fdabaa-24-00123, Ref # Fy24c1ep6, Cardiovascular-Kidney-Metabolic (Ckm) Syndrome Patient-Reported Outcome (Pro) Burden MeasureFda Office Of Acq Grant Svcs$724K1
Aug 2024Comprehensive And Rapid Response For Niaid Research Programs Hiv And Other Infectious Diseases Clinical Research Support Services (Crss)National Institutes Of Health Niaid$75M—
Jul 2024Phase I Randomized Double-Blind Placebo-Controlled Study To Assess Safety, Tolerability, And PharmacokineticsNational Institutes Of Health Nida$3.4M1
Jul 2024First In Human Randomized, Double-Blind, Placebo Controlled Single Ascending Dose (Sad) Phase I StudyNational Institutes Of Health Nida$3.3M2
Jan 2024Niaid Clinical Site Monitoring (Ncsm)National Institutes Of Health Niaid$186M—
Dec 2023Barda Will Implement A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Trial In The US To Evaluate The Safety And Efficacy Of Novel Host-Directed Therapeutic Candidates In Hospitalized Adults With Ards.Barda - Aspr / Daappo / Barda Dcma$222M1
Is this your company?

Claim this profile free, and see the open contracts that fit what you win: who else bids, what the government paid last time, and what to bid.

Claim this profile freeCompete with Ppd Development LP →
From federal contract award records (SAM.gov), base awards over $10K since fiscal year 2024, updated daily. Values include options where reported.
ZukoBid is an independent service, not affiliated with or endorsed by any government agency. Figures come from public records and may contain errors; always check the official listing before you bid. Spotted an error about Ppd Development LP? Request a correction.